Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-05-20

AUTHORS

Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Momoko Nishikori, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo

ABSTRACT

The number of patients who are administered immunosuppressive agents has been increasing. Accordingly, more patients face higher risks for developing immunodeficiency-associated lymphoproliferative disorders (LPD). Although immunodeficiency-associated LPD are distinct from other lymphoid neoplasms in terms of their immunocompromised backgrounds, little is known about the impact of lymphopenia at diagnosis on survival in patients with these LPD. Seventy-one immunodeficiency-associated LPD in Kyoto University Hospital (post-transplant LPD (PTLD), n = 26; other iatrogenic immunodeficiency-associated LPD, n = 45) were reviewed and analyzed. The median age at diagnosis was 63 years (range, 3–83). Diffuse large B cell lymphoma was the most common subtype (n = 33), followed by Hodgkin lymphoma (n = 12), B cell monomorphic LPD not specified (n = 11), and polymorphic LPD or early-phase diseases (n = 15). The median follow-up period for survivors was 2.5 years and overall survival (OS) and progression-free survival (PFS) at 2.5 years were 75% and 67%, respectively. Multivariate analysis showed that lymphopenia (≤ 800/μL) at diagnosis predicted inferior OS (HR, 3.72; P = 0.043) and PFS (HR, 3.82; P = 0.012). Serum albumin values also strongly affected OS (> 3.18 g/dL vs. ≤ 3.18 g/dL; HR, 0.21; P = 0.010) and PFS (HR, 0.26; P = 0.013). Lymphopenia at diagnosis is suggested to predict inferior OS and PFS in patients with immunodeficiency-associated LPDs. Immunocompromised status might affect disease progression in these distinct lymphoid neoplasms growing under immunocompromised backgrounds. More... »

PAGES

1565-1573

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-020-04084-5

DOI

http://dx.doi.org/10.1007/s00277-020-04084-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1127761790

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32436013


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitals, University", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Deficiency Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoproliferative Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watanabe", 
        "givenName": "Mizuki", 
        "id": "sg:person.016572701574.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016572701574.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanda", 
        "givenName": "Junya", 
        "id": "sg:person.01100640630.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100640630.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hishizawa", 
        "givenName": "Masakatsu", 
        "id": "sg:person.01133351543.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133351543.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishikori", 
        "givenName": "Momoko", 
        "id": "sg:person.01302524155.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302524155.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondo", 
        "givenName": "Tadakazu", 
        "id": "sg:person.0666225507.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666225507.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamashita", 
        "givenName": "Kouhei", 
        "id": "sg:person.0700464544.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700464544.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takaori-Kondo", 
        "givenName": "Akifumi", 
        "id": "sg:person.0743352217.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743352217.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrclinonc.2012.111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052116790", 
          "https://doi.org/10.1038/nrclinonc.2012.111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11899-013-0162-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053692799", 
          "https://doi.org/10.1007/s11899-013-0162-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-019-0549-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113050762", 
          "https://doi.org/10.1186/s40425-019-0549-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12307-018-00219-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111641987", 
          "https://doi.org/10.1007/s12307-018-00219-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2009.131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010683878", 
          "https://doi.org/10.1038/modpathol.2009.131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-019-0380-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111657322", 
          "https://doi.org/10.1038/s41375-019-0380-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-05-20", 
    "datePublishedReg": "2020-05-20", 
    "description": "The number of patients who are administered immunosuppressive agents has been increasing. Accordingly, more patients face higher risks for developing immunodeficiency-associated lymphoproliferative disorders (LPD). Although immunodeficiency-associated LPD are distinct from other lymphoid neoplasms in terms of their immunocompromised backgrounds, little is known about the impact of lymphopenia at diagnosis on survival in patients with these LPD. Seventy-one immunodeficiency-associated LPD in Kyoto University Hospital (post-transplant LPD (PTLD), n\u00a0=\u200926; other iatrogenic immunodeficiency-associated LPD, n\u00a0=\u200945) were reviewed and analyzed. The median age at diagnosis was 63\u00a0years (range, 3\u201383). Diffuse large B cell lymphoma was the most common subtype (n\u00a0=\u200933), followed by Hodgkin lymphoma (n\u00a0=\u200912), B cell monomorphic LPD not specified (n\u00a0=\u200911), and polymorphic LPD or early-phase diseases (n\u00a0=\u200915). The median follow-up period for survivors was 2.5\u00a0years and overall survival (OS) and progression-free survival (PFS) at 2.5\u00a0years were 75% and 67%, respectively. Multivariate analysis showed that lymphopenia (\u2264\u2009800/\u03bcL) at diagnosis predicted inferior OS (HR, 3.72; P\u00a0=\u20090.043) and PFS (HR, 3.82; P\u00a0=\u20090.012). Serum albumin values also strongly affected OS (>\u20093.18\u00a0g/dL vs. \u2264\u20093.18\u00a0g/dL; HR, 0.21; P\u00a0=\u20090.010) and PFS (HR, 0.26; P\u00a0=\u20090.013). Lymphopenia at diagnosis is suggested to predict inferior OS and PFS in patients with immunodeficiency-associated LPDs. Immunocompromised status might affect disease progression in these distinct lymphoid neoplasms growing under immunocompromised backgrounds.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-020-04084-5", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "keywords": [
      "immunodeficiency-associated lymphoproliferative disorders", 
      "progression-free survival", 
      "inferior overall survival", 
      "overall survival", 
      "lymphoproliferative disorders", 
      "lymphoid neoplasms", 
      "diffuse large B-cell lymphoma", 
      "large B-cell lymphoma", 
      "impact of lymphopenia", 
      "polymorphic lymphoproliferative disorder", 
      "early-phase disease", 
      "survival of patients", 
      "number of patients", 
      "serum albumin values", 
      "Kyoto University Hospital", 
      "B-cell lymphoma", 
      "distinct lymphoid neoplasms", 
      "median follow", 
      "immunocompromised status", 
      "median age", 
      "more patients", 
      "immunosuppressive agents", 
      "Hodgkin's lymphoma", 
      "University Hospital", 
      "common subtype", 
      "disease progression", 
      "cell lymphoma", 
      "high risk", 
      "albumin values", 
      "lymphopenia", 
      "patients", 
      "multivariate analysis", 
      "diagnosis", 
      "survival", 
      "lymphoma", 
      "neoplasms", 
      "disorders", 
      "years", 
      "hospital", 
      "follow", 
      "subtypes", 
      "disease", 
      "survivors", 
      "progression", 
      "age", 
      "risk", 
      "background", 
      "status", 
      "agents", 
      "period", 
      "number", 
      "impact", 
      "analysis", 
      "values", 
      "terms"
    ], 
    "name": "Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders", 
    "pagination": "1565-1573", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1127761790"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-020-04084-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32436013"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-020-04084-5", 
      "https://app.dimensions.ai/details/publication/pub.1127761790"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_863.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-020-04084-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04084-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04084-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04084-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04084-5'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      21 PREDICATES      105 URIs      91 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-020-04084-5 schema:about N1082d20f2f384e3a9e9907d3d6d69611
2 N14cc291ca29e478faa68fa1b1fe6ce98
3 N1796d51c687e4daba46eceaaca3e1f9a
4 N1f94601f731a4350b15a4d7c67d1b848
5 N294d1f02a3274b5ab14419cf57554c8e
6 N2a34883ae9744295aa55568d663c1078
7 N2b4b92895aa147c08378ad0056204c08
8 N3184b1a7926f4ae28a519b1dc3051e62
9 N443b8da337bb4365bb1c45ea84dd7655
10 N678a65ebb9c045b6a09c40cd02fa3aac
11 N890299e2e40246eba03305824349d8f5
12 N8af201c076574c628240feba3c36193e
13 Na353bf5992ee4917ae22f74faabdd550
14 Nab0640ce13b1476797fb3dd0bbfe812d
15 Nac91704d0e3e4d1bb982d7bccd0ed186
16 Naea7057529ed494094754cc059ac0484
17 Nd1f7531ddd0e4afdb8ec16ae33684c84
18 Ndb999b36f8a74144b00bbfad92e223a0
19 Nf01f1f006d7344dd857587fefb7258d4
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N513c2975a80c41108f3986ba7b0c50d3
23 schema:citation sg:pub.10.1007/s11899-013-0162-5
24 sg:pub.10.1007/s12307-018-00219-5
25 sg:pub.10.1038/modpathol.2009.131
26 sg:pub.10.1038/nrclinonc.2012.111
27 sg:pub.10.1038/s41375-019-0380-5
28 sg:pub.10.1186/s40425-019-0549-5
29 schema:datePublished 2020-05-20
30 schema:datePublishedReg 2020-05-20
31 schema:description The number of patients who are administered immunosuppressive agents has been increasing. Accordingly, more patients face higher risks for developing immunodeficiency-associated lymphoproliferative disorders (LPD). Although immunodeficiency-associated LPD are distinct from other lymphoid neoplasms in terms of their immunocompromised backgrounds, little is known about the impact of lymphopenia at diagnosis on survival in patients with these LPD. Seventy-one immunodeficiency-associated LPD in Kyoto University Hospital (post-transplant LPD (PTLD), n = 26; other iatrogenic immunodeficiency-associated LPD, n = 45) were reviewed and analyzed. The median age at diagnosis was 63 years (range, 3–83). Diffuse large B cell lymphoma was the most common subtype (n = 33), followed by Hodgkin lymphoma (n = 12), B cell monomorphic LPD not specified (n = 11), and polymorphic LPD or early-phase diseases (n = 15). The median follow-up period for survivors was 2.5 years and overall survival (OS) and progression-free survival (PFS) at 2.5 years were 75% and 67%, respectively. Multivariate analysis showed that lymphopenia (≤ 800/μL) at diagnosis predicted inferior OS (HR, 3.72; P = 0.043) and PFS (HR, 3.82; P = 0.012). Serum albumin values also strongly affected OS (> 3.18 g/dL vs. ≤ 3.18 g/dL; HR, 0.21; P = 0.010) and PFS (HR, 0.26; P = 0.013). Lymphopenia at diagnosis is suggested to predict inferior OS and PFS in patients with immunodeficiency-associated LPDs. Immunocompromised status might affect disease progression in these distinct lymphoid neoplasms growing under immunocompromised backgrounds.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N0414cee24898422e85bbce9808687b90
35 Nfbc3b21ad6fc472ea30d8814524bddaf
36 sg:journal.1358129
37 schema:keywords B-cell lymphoma
38 Hodgkin's lymphoma
39 Kyoto University Hospital
40 University Hospital
41 age
42 agents
43 albumin values
44 analysis
45 background
46 cell lymphoma
47 common subtype
48 diagnosis
49 diffuse large B-cell lymphoma
50 disease
51 disease progression
52 disorders
53 distinct lymphoid neoplasms
54 early-phase disease
55 follow
56 high risk
57 hospital
58 immunocompromised status
59 immunodeficiency-associated lymphoproliferative disorders
60 immunosuppressive agents
61 impact
62 impact of lymphopenia
63 inferior overall survival
64 large B-cell lymphoma
65 lymphoid neoplasms
66 lymphoma
67 lymphopenia
68 lymphoproliferative disorders
69 median age
70 median follow
71 more patients
72 multivariate analysis
73 neoplasms
74 number
75 number of patients
76 overall survival
77 patients
78 period
79 polymorphic lymphoproliferative disorder
80 progression
81 progression-free survival
82 risk
83 serum albumin values
84 status
85 subtypes
86 survival
87 survival of patients
88 survivors
89 terms
90 values
91 years
92 schema:name Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders
93 schema:pagination 1565-1573
94 schema:productId N3bb442da272444728d0b841db917a216
95 Na6c53c86da2340f2a6187c0f4bb8483b
96 Ne9c2b595a5a643b9bb081fd821eab3db
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1127761790
98 https://doi.org/10.1007/s00277-020-04084-5
99 schema:sdDatePublished 2022-12-01T06:42
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N2ae7feecb1104e4c9abf14ab2d6041e8
102 schema:url https://doi.org/10.1007/s00277-020-04084-5
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N0414cee24898422e85bbce9808687b90 schema:volumeNumber 99
107 rdf:type schema:PublicationVolume
108 N1082d20f2f384e3a9e9907d3d6d69611 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Survival Analysis
110 rdf:type schema:DefinedTerm
111 N13c71d8030554f0aa86b470a091947ed rdf:first sg:person.0743352217.37
112 rdf:rest rdf:nil
113 N14cc291ca29e478faa68fa1b1fe6ce98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N1796d51c687e4daba46eceaaca3e1f9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Child
118 rdf:type schema:DefinedTerm
119 N1f94601f731a4350b15a4d7c67d1b848 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Retrospective Studies
121 rdf:type schema:DefinedTerm
122 N222a78d206c148f98bf29b7f01d99c90 rdf:first sg:person.01302524155.21
123 rdf:rest N93a33a71ff0b4cd8a5576bc62204309e
124 N294d1f02a3274b5ab14419cf57554c8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Lymphopenia
126 rdf:type schema:DefinedTerm
127 N2a34883ae9744295aa55568d663c1078 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Young Adult
129 rdf:type schema:DefinedTerm
130 N2ae7feecb1104e4c9abf14ab2d6041e8 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N2b4b92895aa147c08378ad0056204c08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Adult
134 rdf:type schema:DefinedTerm
135 N3184b1a7926f4ae28a519b1dc3051e62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Aged
137 rdf:type schema:DefinedTerm
138 N3bb442da272444728d0b841db917a216 schema:name pubmed_id
139 schema:value 32436013
140 rdf:type schema:PropertyValue
141 N443b8da337bb4365bb1c45ea84dd7655 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Male
143 rdf:type schema:DefinedTerm
144 N513c2975a80c41108f3986ba7b0c50d3 rdf:first sg:person.016572701574.43
145 rdf:rest N8a30d9b4c89f4c4baf51b27d427d8ec1
146 N57e7566059e4470fa0fd679a952b6507 rdf:first sg:person.01133351543.21
147 rdf:rest N222a78d206c148f98bf29b7f01d99c90
148 N678a65ebb9c045b6a09c40cd02fa3aac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Immunologic Deficiency Syndromes
150 rdf:type schema:DefinedTerm
151 N67d07974e5674528b16a6a6fb62b2bf7 rdf:first sg:person.0700464544.66
152 rdf:rest N13c71d8030554f0aa86b470a091947ed
153 N890299e2e40246eba03305824349d8f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 N8a30d9b4c89f4c4baf51b27d427d8ec1 rdf:first sg:person.01100640630.10
157 rdf:rest N57e7566059e4470fa0fd679a952b6507
158 N8af201c076574c628240feba3c36193e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Prognosis
160 rdf:type schema:DefinedTerm
161 N93a33a71ff0b4cd8a5576bc62204309e rdf:first sg:person.0666225507.36
162 rdf:rest N67d07974e5674528b16a6a6fb62b2bf7
163 Na353bf5992ee4917ae22f74faabdd550 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Aged, 80 and over
165 rdf:type schema:DefinedTerm
166 Na6c53c86da2340f2a6187c0f4bb8483b schema:name dimensions_id
167 schema:value pub.1127761790
168 rdf:type schema:PropertyValue
169 Nab0640ce13b1476797fb3dd0bbfe812d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Lymphoproliferative Disorders
171 rdf:type schema:DefinedTerm
172 Nac91704d0e3e4d1bb982d7bccd0ed186 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Middle Aged
174 rdf:type schema:DefinedTerm
175 Naea7057529ed494094754cc059ac0484 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Child, Preschool
177 rdf:type schema:DefinedTerm
178 Nd1f7531ddd0e4afdb8ec16ae33684c84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Hospitals, University
180 rdf:type schema:DefinedTerm
181 Ndb999b36f8a74144b00bbfad92e223a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Japan
183 rdf:type schema:DefinedTerm
184 Ne9c2b595a5a643b9bb081fd821eab3db schema:name doi
185 schema:value 10.1007/s00277-020-04084-5
186 rdf:type schema:PropertyValue
187 Nf01f1f006d7344dd857587fefb7258d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Adolescent
189 rdf:type schema:DefinedTerm
190 Nfbc3b21ad6fc472ea30d8814524bddaf schema:issueNumber 7
191 rdf:type schema:PublicationIssue
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
196 schema:name Oncology and Carcinogenesis
197 rdf:type schema:DefinedTerm
198 sg:journal.1358129 schema:issn 0939-5555
199 1432-0584
200 schema:name Annals of Hematology
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01100640630.10 schema:affiliation grid-institutes:grid.258799.8
204 schema:familyName Kanda
205 schema:givenName Junya
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100640630.10
207 rdf:type schema:Person
208 sg:person.01133351543.21 schema:affiliation grid-institutes:grid.258799.8
209 schema:familyName Hishizawa
210 schema:givenName Masakatsu
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133351543.21
212 rdf:type schema:Person
213 sg:person.01302524155.21 schema:affiliation grid-institutes:grid.258799.8
214 schema:familyName Nishikori
215 schema:givenName Momoko
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302524155.21
217 rdf:type schema:Person
218 sg:person.016572701574.43 schema:affiliation grid-institutes:grid.258799.8
219 schema:familyName Watanabe
220 schema:givenName Mizuki
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016572701574.43
222 rdf:type schema:Person
223 sg:person.0666225507.36 schema:affiliation grid-institutes:grid.258799.8
224 schema:familyName Kondo
225 schema:givenName Tadakazu
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666225507.36
227 rdf:type schema:Person
228 sg:person.0700464544.66 schema:affiliation grid-institutes:grid.258799.8
229 schema:familyName Yamashita
230 schema:givenName Kouhei
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700464544.66
232 rdf:type schema:Person
233 sg:person.0743352217.37 schema:affiliation grid-institutes:grid.258799.8
234 schema:familyName Takaori-Kondo
235 schema:givenName Akifumi
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743352217.37
237 rdf:type schema:Person
238 sg:pub.10.1007/s11899-013-0162-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053692799
239 https://doi.org/10.1007/s11899-013-0162-5
240 rdf:type schema:CreativeWork
241 sg:pub.10.1007/s12307-018-00219-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111641987
242 https://doi.org/10.1007/s12307-018-00219-5
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/modpathol.2009.131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010683878
245 https://doi.org/10.1038/modpathol.2009.131
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/nrclinonc.2012.111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052116790
248 https://doi.org/10.1038/nrclinonc.2012.111
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/s41375-019-0380-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111657322
251 https://doi.org/10.1038/s41375-019-0380-5
252 rdf:type schema:CreativeWork
253 sg:pub.10.1186/s40425-019-0549-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113050762
254 https://doi.org/10.1186/s40425-019-0549-5
255 rdf:type schema:CreativeWork
256 grid-institutes:grid.258799.8 schema:alternateName Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan
257 schema:name Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...